Cargando…
Blood and saliva‐derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus‐associated head and neck cancer
BACKGROUND: There is an alarming increase in human papillomavirus‐associated head and neck cancer (HNC), reaching epidemic levels. While patient prognosis is generally good, off‐target treatment effects are associated with decreased quality of life. Thus, non‐invasive strategies to predict treatment...
Autores principales: | Ferrier, Sarah Tadhg, Tsering, Thupten, Sadeghi, Nader, Zeitouni, Anthony, Burnier, Julia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469655/ https://www.ncbi.nlm.nih.gov/pubmed/37526056 http://dx.doi.org/10.1002/cam4.6191 |
Ejemplares similares
-
Uveal Melanoma-Derived Extracellular Vesicles Display Transforming Potential and Carry Protein Cargo Involved in Metastatic Niche Preparation
por: Tsering, Thupten, et al.
Publicado: (2020) -
Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer
por: Zhu, Jie Wei, et al.
Publicado: (2023) -
Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA
por: Zhang, Xuefei, et al.
Publicado: (2023) -
Novel Methylation Patterns Predict Outcome in Uveal Melanoma
por: Ferrier, Sarah Tadhg, et al.
Publicado: (2020) -
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
por: Stecklein, Shane R., et al.
Publicado: (2023)